Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors
Year: 2017
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
Institutions: The University of Texas MD Anderson Cancer Center, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Pharmaceutical Product Development (United States), University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, NanoCarrier (Japan), University of California San Diego, Moores Cancer Center
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W2764334703
